Policy & Regulation
-
Tirzepatide Significantly Reduced A1C and Body Weight in People with Type 2 Diabetes in Two Phase 3 Trials from Lilly's SURPASS Program
2021-07-13INDIANAPOLIS, Feb. 17, 2021 /PRNewswire/ -- Tirzepatide led to significant A1C and body weight reductions from baseline in adults with type 2 diabetes in Eli Lilly and Company's (NYSE: LLY) SURPASS-3 and SURPASS-5 phase 3 clinical trials
-
The global marine coatings will reach 5.3 million tons in the next 4 years, with an average annual growth rate of 6%!
2021-07-09Since the 1940s, modern marine protective coatings have begun to develop. With the birth of zinc-rich coatings, antifouling coatings and other products, marine coatings began to be widely used in military and other fields.
-
Active R&D and strong demand for innovative peptide drugs
2021-07-09With the increasing difficulty of small molecule drug development, global biologics research and development is accelerating and exploding.
-
How to comply with marketing in the post '4+7' era
2021-07-09First, the policy "right" disappeared. Since foreign companies entered the Chinese market, most of their products have enjoyed the "right" to tender level, that is, no matter how many companies are producing this product, foreign compa
-
Limited demand and fierce competition for montmorillonite API
2021-07-09Montelukast is both a "4+7" quantity procurement and "4+7" expansion product, and a national essential drug catalog product.
-
Pharmaceutical industry sales expense ratio hits 8-year high
2021-07-08A pharmaceutical company's annual cost of sales can reach tens of billions! Almost no industry has higher sales expenses than the pharmaceutical industry.
-
The fifth batch of 303 overlapping varieties released
2021-07-08On September 6, the Chinese Pharmaceutical Society released the "Announcement of the Fifth Batch of Excessive Duplication of Drug Reminder Information".
-
National procurement with the expansion of the official launch: the scope of procurement is still the first 25 varieties
2021-07-08The expansion of national procurement with quantity officially started. September 1, Shanghai Sunshine Pharmaceutical Procurement Network announced the "Alliance Area Drug Centralized Procurement Document"
-
The State Council ordered: 'convenience store drug sales' nationwide rollout!
2021-07-08On August 28, the General Office of the State Council issued the "Opinions on Accelerating the Development of Circulation to Promote Commercial Consumption" (hereinafter referred to as "Opinions"), which put forward 20 policy measures
-
Children's medicine receives top-level policy support
2021-07-08On August 27, the official website of the National Health Commission released the "Third Batch of Suggested List of Drugs to Encourage R&D and Declaration for Children", which contains 34 drugs, including some familiar and commonly used drug
-
Polycarbonate manufacturers overhaul, weak price stalemate
2021-07-08It is understood that Wanhua Chemical’s PC equipment production capacity is 210,000 tons/year, 3 production lines, and the maintenance plan for the storage wheel line from July 10 to September 10.
-
Pharmaceutical companies' sales expenses are abnormally high
2021-07-07As soon as the news of the Ministry of Finance's "2019 Annual Inspection of Accounting Information Quality in the Pharmaceutical Industry" was released, the industry wailed and the pharmaceutical sector of the stock market plunged.
-
Behind the prescription outflow: challenges and opportunities for hospital side stores
2021-07-07A few days ago, the Heilongjiang Provincial Drug Administration issued the "Implementation Plan for the Inspection of the Business Quality of Drug Retail Enterprises around Hospitals"
-
The development of China's domestic innovative drugs in overseas markets
2021-07-07On June 16, Fosun Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had recently granted Fast Track designation for its new drug ORIN1001
-
Methanol remains consolidating after market
2021-06-30The Chinese methanol market is in a supply-over-demand pattern, but production is caught in losses. With cost support and supply and demand side suppression, the methanol 2109 contract is expected to continue to oscillate in the aftermarket.
-
The global pure benzene market is expected to restore the balance of supply and demand in the second half of the year
2021-06-28Recently, the global market for pure benzene has been in short supply and prices have risen. Especially in the North American and European markets, the supply of pure benzene in the first half of this year is rarely tight
-
FDA approves first oral blood thinning medication for children
2021-06-28The U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a condition where blood clots form in the veins) directly after they have been tre
-
China's Tianjin Port reaches 10m TEUs in container throughput this year
2021-06-28The container throughput of Tianjin Port in North China's Tianjin municipality exceeded 10 million TEUs this year, an increase of over 20 percent year-on-year, according to the port's operator.
-
Strong increase in global demand for paints and coatings
2021-06-28The strongest surge in industrial coating demand was experienced in China and India.
-
When will the sea freight price increase stop? These giants 'dance' with madness!
2021-06-28In mid-June, the headquarters of COSCO SHIPPING Group ushered in a visiting group from Shaanxi. Leading the team was Liang Gui, member of the Standing Committee of the Shaanxi Provincial Party Committee and Executive Vice Governor, and Li Zhenguo, preside
Hot News
-
ECHEMI平台投诉处罚规则 - ECHEMI platform complaint penalty rules
-
ECHEMI平台禁限售商品目录规则 - Announcement on the list of prohibited sales of Prohibited and Controlled Items on ECHEMI
-
ECHEMI禁售商品发布规则 Rules for the Release of Prohibited Products on ECHEMI.com
-
From August 1st, many shipping companies charge high port congestion fees!
-
Congestion in 116 ports around the world! The increase in freight rates will continue into the first half of next year!
-
Semaglutide initiates Phase III clinical trial of NASH in China
-
GlaxoSmithKline Pharmaceuticals Reports 11% Rise in Q1 Profit Driven by Strong Demand for Vaccines
-
GLP-1 competition: Semaglutide surpasses dulaglutide this year
-
Ecuador pesticides market: imports during 2022 reached 275.6 Mio USD and 53.5 Mio USD in Q1 2023
-
Styrene: Supply And Demand Change